CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 97 filers reported holding CYTOSORBENTS CORP in Q3 2020. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $94,760 | +20.5% | 11,670 | +28.8% | 0.00% | 0.0% |
| Q1 2021 | $78,658 | -5.9% | 9,062 | -13.6% | 0.00% | 0.0% |
| Q4 2020 | $83,565 | -0.1% | 10,485 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $83,618 | -19.4% | 10,485 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $103,802 | +85.3% | 10,485 | +23.7% | 0.00% | +100.0% |
| Q2 2019 | $56,033 | -12.7% | 8,477 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $64,171 | -23.9% | 8,477 | -18.8% | 0.00% | -50.0% |
| Q4 2018 | $84,371 | -37.4% | 10,442 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $134,702 | -99.9% | 10,442 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $119,039,000 | – | 10,442 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $846,000 | 0.90% |
| Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
| Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
| Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
| Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
| Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
| HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
| Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
| Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |